3VFE
Virtual Screening and X-Ray Crystallography for Human Kallikrein 6 Inhibitors with an Amidinothiophene P1 Group
Summary for 3VFE
Entry DOI | 10.2210/pdb3vfe/pdb |
Descriptor | Kallikrein-6, 4-{[(3R)-3-{[(7-methoxynaphthalen-2-yl)sulfonyl](thiophen-3-ylmethyl)amino}-2-oxopyrrolidin-1-yl]methyl}thiophene-2-carboximidamide (3 entities in total) |
Functional Keywords | human kallikrein 6, hk6, serine protease, protein-ligand complex, amidinothiophene, hydrolase |
Biological source | Homo sapiens (human) |
Cellular location | Secreted: Q92876 |
Total number of polymer chains | 1 |
Total formula weight | 24972.40 |
Authors | |
Primary citation | Liang, G.,Chen, X.,Aldous, S.,Pu, S.F.,Mehdi, S.,Powers, E.,Giovanni, A.,Kongsamut, S.,Xia, T.,Zhang, Y.,Wang, R.,Gao, Z.,Merriman, G.,McLean, L.R.,Morize, I. Virtual Screening and X-ray Crystallography for Human Kallikrein 6 Inhibitors with an Amidinothiophene P1 Group. Acs Med.Chem.Lett., 3:159-164, 2012 Cited by PubMed Abstract: A series of compounds with an amidinothiophene P1 group and a pyrrolidinone-sulphonamide scaffold linker was identified as potent inhibitors of human kallikrein 6 by structure-based virtual screening based on the union accessible binding space of serine proteases. As the first series of potent nonmechanism-based hK6 inhibitors, they may be used as tool compounds for target validation. An X-ray structure of a representative compound complexed with hK6, resolved at a resolution of 1.88 Å, revealed that the amidinothiophene moiety bound in the S1 pocket and the pyrrolidinone-sulphonamide linker projected the aromatic tail into the S' pocket. PubMed: 24900446DOI: 10.1021/ml200291e PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.88 Å) |
Structure validation
Download full validation report
